Skip to main content
NCBI home page
Global Advances in Health and Medicine logoLink to Global Advances in Health and Medicine
. 2015 Mar 1;4(2):53–60. doi: 10.7453/gahmj.2014.064

Medication-free Alternatives for Long-term Maintenance of Bipolar Disorder: A Case Series

Alternativas sin medicamentos para el mantenimiento del trastorno bipolar a largo plazo: serie de informes de casos

Michael I Gurevich 1,✉, Cassandra L Robinson 2
PMCID: PMC4424923  PMID: 25984407

Abstract

Psychopharmacological treatment has been the mainstay in long-term maintenance of bipolar disorder (BD) patients for the last 60 years. Conventionally accepted treatment options are primarily based on expert opinion rather than on well-executed, independently funded research. Investigation of maintaining patients without medications using treatment alternatives has been neglected. This clinical case series examines the outcomes of 7 BD patients who experienced a poor response or significant side effects with conventional treatment modalities. Patients were gradually and safely withdrawn from all medications. Treatment strategies were based on an individualized holistic approach using herbs, nutritional supplements, vitamins, amino acids, acupuncture, dietary recommendations, and behavioral modifications. Multiple treatment modalities were combined addressing the etiological causes for BD symptoms. Upon withdrawal from psychotropic medications, patients were free of medication-induced side effects and obtained psychiatric stability for at least 10 months. Further research is needed to investigate the long-term outcomes of BD treatment modalities based on well-defined successful outcome criteria, such as reduction in symptoms, improvement in quality of life, overall health outcomes, and cost effectiveness.

Keywords: Bipolar, medication-free maintenance treatment, integrative

References

  • 1.Hirschfeld RMA, Bowden CL, Gitlin MJ, et al. Practice guideline for the treatment of patients with bipolar disorder. In: American Psychiatric Association, editor. American Psychiatric Association practice guidelines for the treatment of psychiatric disorders. Washington, DC: American Psychiatric Association; 2002: 547–634. [Google Scholar]
  • 2.Mukherjee S, Sackeim H, Schnur D. Electroconvulsive therapy of acute manic episodes: a review of 50 years’ experience. Am J Psychiatry. 1994; 151(2): 169–76. [DOI] [PubMed] [Google Scholar]
  • 3.Sikdar S, Kulhara P, Avasthi A, Singh H. Combined chlorpromazine and electroconvulsive therapy in mania. Br J Psychiatry. 1994; 164(6): 806–10. [DOI] [PubMed] [Google Scholar]
  • 4.Small JG, Klapper MH, Kellams JJ, et al. Electroconvulsive treatment compared with lithium in the management of manic states. Arch Gen Psychiatry. 1988; 45(8): 727–32. [DOI] [PubMed] [Google Scholar]
  • 5.Baldessarini R, Henk H, Sklar A, Chang J, Leahy L. Psychotropic medications for patients with bipolar disorder in the United States: polytherapy and adherence. Psychiatr Serv. 2008; 59(10): 1175–83. [DOI] [PubMed] [Google Scholar]
  • 6.Freeman MP, Stoll AL. Mood stabilizer combinations: a review of safety and efficacy. Am J Psychiatry. 1998; 155(1): 12–21. [DOI] [PubMed] [Google Scholar]
  • 7.Verdoux H, Tournier M, Bégaud B. Antipsychotic prescribing trends: a review of pharmaco-epidemiological studies. Acta Psychiatr Scand. 2010; 121(1): 4–10. [DOI] [PubMed] [Google Scholar]
  • 8.Gallego JA, Bonetti J, Zhang J, Kane JM, Correll CU. Prevalence and correlates of antipsychotic polypharmacy: a systematic review and metaregression of global and regional trends from the 1970s to 2009. Schizophr Res. 2012; 138(1): 18–28. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 9.Olfson M, Blanco C, Liu SM, Wang S, Correll CU. National trends in the office-based treatment of children, adolescents, and adults with antipsychotics. Arch Gen Psychiatry. 2012; 69(12): 1247–56. [DOI] [PubMed] [Google Scholar]
  • 10.Stephenson CP, Karanges E, McGregor IS. Trends in the utilisation of psychotropic medications in Australia from 2000 to 2011. Aust N Z J Psychiatry. 2013; 47(1): 74–87. [DOI] [PubMed] [Google Scholar]
  • 11.Buoli M, Marta S, Carlo AA. Is the combination of a mood stabilizer plus an antipsychotic more effective than mono-therapies in long-term treatment of bipolar disorder? A systematic review. J Affect Disord. 2013: 1–7. [DOI] [PubMed] [Google Scholar]
  • 12.Bowden CL, Calabrese JR, Sachs G, et al. A placebo-controlled 18-month trial of lamotrigine and lithium maintenance treatment in recently manic or hypomanic patients with bipolar I disorder. Arch Gen Psychiatry. 2003; 60(4): 392–400. [DOI] [PubMed] [Google Scholar]
  • 13.Thase ME, Bhargava M, Sachs GS. Treatment of bipolar depression: current status, continued challenges, and the STEP-BD approach. Psychiatr Clin North Am. 2003; 26(2): 495–518. [DOI] [PubMed] [Google Scholar]
  • 14.Baldessarini RJ, Tondo L, Viguera A. Discontinuing lithium maintenance treatment in bipolar disorders: risks and implications. Bipolar Disord. 1999; 1(1): 17–24. [DOI] [PubMed] [Google Scholar]
  • 15.Suppes T, Baldessarini RJ, Faedda GL, Tondo L, Tohen M. Discontinuation of maintenance treatment in bipolar disorder: risks and implications. Harv Rev Psychiatry. 1993; 1(3): 131–44. [DOI] [PubMed] [Google Scholar]
  • 16.Baldessarini RJ, Tondo L. Recurrence risk in bipolar manic-depressive disorders after discontinuing lithium maintenance treatment: an overview. Clin Drug Investig. 1998; 15(4): 337–51. [DOI] [PubMed] [Google Scholar]
  • 17.Suppes T, Baldessarini RJ, Faedda GL, Tohen M. Risk of recurrence following discontinuation of lithium treatment in bipolar disorder. Arch Gen Psychiatry. 1991; 48(12): 1082–8. [DOI] [PubMed] [Google Scholar]
  • 18.Sachs GS, Thase ME. Bipolar disorder therapeutics: maintenance treatment. Biol Psychiatry. 2000; 48(6): 573–81. [DOI] [PubMed] [Google Scholar]
  • 19.Judd LL, Akiskal HS, Schettler PJ, et al. The long-term natural history of the weekly symptomatic status of bipolar I disorder. Arch Gen Psychiatry. 2002; 59(6): 530–7. [DOI] [PubMed] [Google Scholar]
  • 20.Judd LL, Akiskal HS, Schettler PJ, et al. A prospective investigation of the natural history of the long-term weekly symptomatic status of bipolar II disorder. Arch Gen Psychiatry. 2003; 60(3): 261–9. [DOI] [PubMed] [Google Scholar]
  • 21.Peselow ED, Fieve RR, Difiglia C, Sanfilipo MP. Lithium prophylaxis of bipolar illness. The value of combination treatment. Br J Psychiatry. 1994; 164(2): 208–14. [DOI] [PubMed] [Google Scholar]
  • 22.Kahneman D. editor. Thinking, fast and slow. New York, NY: Farrar, Straus and Giroux; 2011. [Google Scholar]
  • 23.Tversky A, Kahneman D. Judgement under uncertainty: heuristics and biases. Science. 1974; 185(4157): 1124–31. [DOI] [PubMed] [Google Scholar]
  • 24.Zandi PP, Judy JT. The promise and reality of pharmacogenetics in psychiatry. Psychiatr Clin North Am. 2010; 33(1): 181–224. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 25.Gianfrancesco FD, Rajagopalan K, Sajatovic M, Wang R. Treatment adherence among patients with bipolar or manic disorder taking atypical and typical antipsychotics. J Clin Psychiatry. 2006; 67(2): 222–32. [DOI] [PubMed] [Google Scholar]
  • 26.Zarate CA. Antipsychotic drug side effect issues in bipolar manic patients. J Clin Psychiatry. 2000;61(suppl 8):52–61. [PubMed] [Google Scholar]
  • 27.Kaplan BJ, Simpson JS, Ferre RC, Gorman CP, McMullen DM, Crawford SG. Effective mood stabilization with a chelated mineral supplement: an open-label trial in bipolar disorder. J Clin Psychiatry. 2001; 62(12): 936–44. [DOI] [PubMed] [Google Scholar]
  • 28.Gardner A, Kaplan BJ, Rucklidge JJ, Jonsson BH, Humble MB. The potential of nutritional therapy. Science. 2010; 327(5963): 268. [DOI] [PubMed] [Google Scholar]
  • 29.Akhondzadeh S, Gerbarg PL, Brown RP. Nutrients for prevention and treatment of mental health disorders. Psychiatr Clin North Am. 2013; 36(1): 25–36. [DOI] [PubMed] [Google Scholar]
  • 30.Lakhan SE, Vieira KF. Nutritional therapies for mental disorders. Nutr J. 2008; 7: 2. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 31.Frazier EA, Fristad MA, Arnold LE. Feasibility of a nutritional supplement as treatment for pediatric bipolar spectrum disorders. J Altern Complement Med. 2012; 18(7): 678–85. [DOI] [PubMed] [Google Scholar]
  • 32.Gately D, Kaplan B. Database analysis of adults with bipolar disorder consuming a micronutrient formula. Clin Med Psychiatry. 2009; 4: 3–16. [DOI] [PMC free article] [PubMed] [Google Scholar]
  • 33.Popper C. Do vitamins or minerals (apart from lithium) have mood-stabilizing effects? J Clin Psychiatry. 2001;62(12):933–5. [DOI] [PubMed] [Google Scholar]
  • 34.Sylvia LG, Peters AT, Deckersbach T, Nierenberg AA. Nutrient-based therapies for bipolar disorder: a systematic review. Psychother Psychosom. 2013; 82(1): 10–9. [DOI] [PubMed] [Google Scholar]
  • 35.Sarris J, Mischoulon D, Schweitzer I. Adjunctive nutraceuticals with standard pharmacotherapies in bipolar disorder: a systematic review of clinical trials. Bipolar Disord. 2011;13(5-6):454–65. [DOI] [PubMed] [Google Scholar]
  • 36.Busner J, Targum SD. The Clinical Global Impressions Scale: applying a research tool in clinical practice. Psychiatry. 2007; 4(7): 28–37. [PMC free article] [PubMed] [Google Scholar]
  • 37.Gottschall EG. editor. Breaking the vicious cycle: intestinal health through diet. Baltimore, ON: Kirkton Press; 1994. [Google Scholar]
  • 38.Haas SV, Haas MP. The treatment of celiac disease with the specific carbohydrate diet; report on 191 additional cases. Am J Gastroenterol. 1955; 23(4): 344–60. [PubMed] [Google Scholar]
  • 39.Ulsamer B. editor. The art and practice of family constellations. Leading family constellations as developed by Bert Hellinger. Heidelberg, Germany: Carl Auer International; 2008. [Google Scholar]
  • 40.Waite WL, Holder MD. Assessment of the emotional freedom technique. Sci Rev Ment Health Pract. 2003; 2(1): 1–10. [Google Scholar]
  • 41.Salas MM, Brooks AJ, Rowe JE. The immediate effect of a brief energy psychology intervention (Emotional Freedom Techniques) on specific phobias: a pilot study. Explore. 2011; 7(3): 155–61. [DOI] [PubMed] [Google Scholar]
  • 42.Davidson PR, Parker KCH. Eye movement desensitization and reprocessing (EMDR): a meta-analysis. J Consult Clin Psychol. 2001; 69(2): 305–16. [DOI] [PubMed] [Google Scholar]
  • 43.Shapiro F, Solomon RM. Eye movement desensitization and reprocessing. In: Weiner IB, Craighead WE, editors. Corsini encyclopedia of psychology. Hoboken, NJ: John Wiley & Sons, Inc.; 2010. [Google Scholar]
  • 44.Klinghardt D. editor. Applied psycho-neurobiology seminar and manual. Redmond, WA: Klinghardt Academy; 2012. [Google Scholar]
  • 45.Salzberg S, Goldstein J. editors. Insight meditation. Louisville, CO: Sounds True (Audio CD); 2004. [Google Scholar]
  • 46.Dosch P, Dosch MP. editors. Manual of neural therapy according to Huneke. New York, NY: Thieme; 2007. [Google Scholar]
  • 47.Dosch MP. editor. Atlas of neural therapy with local anesthetics. New York, NY: Thieme; 2012. [Google Scholar]
  • 48.Frances A. editor. Saving normal: an insider's revolt against out-of-control psychiatric diagnosis, DSM-5, Big Pharma, and the medicalization of ordinary life. New York, NY: William Morrow Paperbacks; 2012. [Google Scholar]
  • 49.Frances A. How many psychiatric diagnoses fit on the head of a pin? Aust N Z J Psychiatry. 2014;48(11):1067–8. [DOI] [PubMed] [Google Scholar]
  • 50.Frances A. ICD, DSM and the Tower of Babel. Aust N Z J Psychiatry. 2014; 48(4): 371–3. [DOI] [PubMed] [Google Scholar]
  • 51.Frances A. The new crisis of confidence in psychiatric diagnosis. Ann Intern Med. 2013; 159(10): 720. [DOI] [PubMed] [Google Scholar]
  • 52.Healy D. editor. Pharmageddon. Oakland, CA: University of California Press; 2013. [Google Scholar]
  • 53.Mrazek DA, Hornberger JC, Altar CA, et al. A review of the clinical, economic and social burden of treatment-resistant depression: 1996-2013. Psychiatr Serv. 2014; 65(8): 977–87. [DOI] [PubMed] [Google Scholar]
  • 54.Rucklidge JJ, Kaplan BJ. Broad-spectrum micronutrient formulas for the treatment of psychiatric symptoms: a systematic review. Expert Rev Neurother. 2013; 13(1): 49–73. [DOI] [PubMed] [Google Scholar]
  • 55.Scarna A, Gijsman HJ, McTavish SF, Harmer CJ, Cowen PJ, Goodwin GM. Effects of a branched-chain amino acid drink in mania. Br J Psychiatry. 2003; 182: 210–3. [DOI] [PubMed] [Google Scholar]
  • 56.Stoll AL, Sachs GS, Cohen BM, Lafer B, Christensen JD, Renshaw PF. Choline in the treatment of rapid-cycling bipolar disorder: clinical and neurochemical findings in lithium-treated patients. Biol Psychiatry. 1996; 40(5): 382–8. [DOI] [PubMed] [Google Scholar]
  • 57.Sartori HE. Lithium orotate in the treatment of alcoholism and related conditions. Alcohol. 1986; 3(2): 97–100. [DOI] [PubMed] [Google Scholar]
  • 58.Sarris J, Lake J, Hoenders R. Bipolar disorder and complementary medicine: current evidence, safety issues, and clinical considerations. J Altern Comp Med. 2011; 17(10): 881–90. [DOI] [PubMed] [Google Scholar]

Articles from Global Advances in Health and Medicine are provided here courtesy of SAGE Publications

RESOURCES